Cannabiz co-founders Martin Lane and Kim McKay are joined by editor-at-large Rhys Cohen to review the latest happenings in cannabis, including:

  • The Dean of the Faculty of Pain Medicine’s anti-cannabis rant
  • How the industry should respond to PR crises
  • Kim’s vision for Women in Cannabis
  • New York’s plans for legalisation

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Elementum integer enim neque volutpat ac tincidunt vitae semper quis. Eu lobortis elementum nibh tellus molestie nunc. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Magnis dis parturient montes nascetur ridiculus. Dui id ornare arcu odio ut sem. Nisl nunc mi ipsum faucibus vitae.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...

Join the Conversation

1 Comment

  1. I think that this is a bit of an over-reaction to Michael Vagg’s comments. He is speaking on behalf of, but probably not for, the FPM. Many professions working in pain medicine acknowledge that an individual patient has the right to use medicinal cannabis but we won’t prescribe it ourselves.